RULID 50 mg, scored tablet for oral suspension 16 tablets
Active ingredients: Roxithromycin
Commercialized according to BDPMDispensing in France: Prescription only
Scored tablet for oral suspension16 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- RULID 50 mg, comprimé sécable pour suspension buvable
- Pharmaceutical form
- comprimé sécable pour suspension buvable
- Route of administration
- orale
- Presentation description
- plaquette(s) aluminium de 16 comprimé(s)
- Marketing authorisation holder
- AMDIPHARM
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 15 Nov 2021
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68658161CIP73437329CIP133400934373299Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ROXITHROMYCINEcomprimé | 50 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.